Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- DOCS +24.9%, PINS +19.4%, AFRM +15.4%, LEU +13.3%, EXPE +11% (also reinstates dividend), NET +10.9%, TTWO +9.3%, MPWR +7.9% (also authorizes new $500 mln share repurchase program), STEP +7.1%, PWP +7%, SYNA +6.9%, CLSK +6.9%, ROAD +6.5%, G +6.3% (also authorizes new $500 mln share repurchase program; also increase dividend), FTNT +5.6%, IBEX +5.5%, OTEX +5%, SSNC +4.5%, PRLB +4%, QNST +3.3%, EHC +3.2%, BYD +3.1%, LGF.A +3%, MTD +2.8%, KIM +2.6%, PRO +2.3%, MHK +2.1%, EXPO +1.4% (also increases dividend), PCTY +1.4%, CPT +1.1%, POST +1.1%
Other news:
- DC +13.1% (amended Richmond Hill option agreement to acquire LAC Minerals)
- KRMD +4.9% (signs agreement with global pharma co to develop SCIg therapy infusion system)
- TBN +4.2% (EP 98 Operational Update: SS-2H ST1 Stimulation Delivers Material Step Change in Beetaloo Completion Efficiency)
- SILV +3.3% (SILV securityholders approve transaction with CDE)
- CDLR +3.3% (Strengthens Its Position in the Polish Offshore Wind Market With the Signing of a New Vessel Reservation Agreement)
- SLRN +3.2% (ALMS and SLRN to merge)
- SARO +3.1% (signs deal with major Middle East airline to provide aftermarket services)
- NVO +2.5% (reports interim results from the phase 3 FRONTIER3 trial)
- ETON +1.9% (USPTO has granted the Company U.S. Patent No. 12,214,010, covering its ET-600 product candidate's proprietary formulation of desmopressin oral solution) PROV +1.7% (CFO steps down)
- KLG +1.6% (increases dividend)
- SNY +1.6% (executes share buyback agreement for up to €2 billion)
- ASR +1.4% (reports Jan traffic)
- ESCA +1.4% (names new CEO)
Analyst comments:
- DENN +5.3% (upgraded to Outperform from Neutral at Wedbush)
- DECK +1.3% (upgraded to Buy from Neutral at Citigroup)
- HON +0.8% (upgraded to Buy from Hold at Deutsche Bank)